---
schema_version: "secwatch.filing_event.v1"
accession: "0000721371-26-000003"
form_type: "8-K"
ticker: "CAH"
cik: "0000721371"
company_name: "CARDINAL HEALTH INC"
filed_at: "2026-01-13T23:59:59+00:00"
generated_at: "2026-05-16T10:44:29.791907+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Cardinal Health raises FY2026 non-GAAP EPS outlook to at least $10.00, up from $9.65-$9.85

## Summary
- Raises FY2026 non-GAAP diluted EPS guidance to at least $10.00 from prior range of $9.65-$9.85.
- Specialty revenues expected to exceed $50B in FY2026, a 16% CAGR over three years.
- Successfully transitioned distribution agreements for all drugs affected by 2026 Medicare Drug Price Negotiation Program.
- Launched ContinuCare Pathway program; Publix enrolled ~1,400 pharmacies, expanding to over 11,000 retail and grocery pharmacies.

## SEC filing metadata
- accession: 0000721371-26-000003
- form_type: 8-K
- ticker: CAH
- cik: 0000721371
- company_name: CARDINAL HEALTH INC
- filed_at: 2026-01-13T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/721371/000072137126000003/0000721371-26-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/721371/000072137126000003/cah-20260113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000721371-26-000003
- JSON: https://secwatch.observer/filing/0000721371-26-000003.json
- Plain text: https://secwatch.observer/filing/0000721371-26-000003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.